Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Bayer reports K+ channel modulators for CNS disorders

May 10, 1996

5-HT reuptake inhibitors reported by HMR

May 10, 1996

Taisho discloses new series of sigma-receptor ligands

May 10, 1996

Santen reports sigma receptor ligands as potential psychopharmacologic drugs

May 10, 1996

Yakult claims ACAT inhibitor from natural source

May 10, 1996

Hoechst claims bile acid sequestrants

May 10, 1996

Corydalin: ACAT inhibitor from natural source

May 10, 1996

Hoechst claims treatment for chronic polyarthritis

May 10, 1996

New immunosuppressants from Tsumura

May 10, 1996

Bayer claimes quinolones and naphthyridines

May 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...